Valerio Therapeutics Société anonyme (EPA:ALVIO)
France flag France · Delayed Price · Currency is EUR
0.1666
+0.0006 (0.36%)
May 14, 2026, 5:28 PM CET

EPA:ALVIO Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-4.9-23.93-20.34-19.56-5.94
Depreciation & Amortization
4.4312.980.480.530.6
Loss (Gain) From Sale of Assets
--0.79---
Asset Writedown & Restructuring Costs
---0.21-0.18
Stock-Based Compensation
0.070.390.510.720.22
Other Operating Activities
1.042.982.631.780.86
Change in Other Net Operating Assets
1.19-4.09-0.676.88-4.14
Operating Cash Flow
1.84-12.46-17.39-9.44-8.57
Capital Expenditures
-1.32-0.32-0.18-0.49-0.14
Divestitures
--1.08---
Investment in Securities
0.150.010.010.080.07
Other Investing Activities
-0-0-0-
Investing Cash Flow
-1.16-1.39-0.18-0.41-0.07
Long-Term Debt Issued
----3.11
Total Debt Issued
----3.11
Long-Term Debt Repaid
-0.81-1.36-1.23-1.51-0.49
Net Debt Issued (Repaid)
-0.81-1.36-1.23-1.512.62
Issuance of Common Stock
0.040.0212.147.979.35
Repurchase of Common Stock
---0.13--
Other Financing Activities
05.54-0.0300
Financing Cash Flow
-0.774.2110.766.4611.98
Foreign Exchange Rate Adjustments
-0-0.120.240.090.03
Miscellaneous Cash Flow Adjustments
-4.09-1.210-
Net Cash Flow
-0.1-5.66-7.77-3.33.36
Free Cash Flow
0.52-12.78-17.57-9.93-8.71
Free Cash Flow Margin
20.25%-712.72%-976.33%-688.22%-214.45%
Free Cash Flow Per Share
0.00-0.08-0.13-0.09-0.10
Levered Free Cash Flow
-0.745.77-9.79-2.92-7.36
Unlevered Free Cash Flow
-0.565.77-9.7-1.55-6.83
Change in Working Capital
1.19-4.09-0.676.88-4.14
Source: S&P Global Market Intelligence. Standard template. Financial Sources.